We conducted a prospective pilot study to evaluate the potential role of combined systemic antifungal and liposomal amphotericin B lock therapy in children with intestinal insufficiency with fungal catheter-related bloodstream infections whose central venous catheters had not been removed” McGhee et al (2016).
Abstract:
We conducted a prospective pilot study to evaluate the potential role of combined systemic antifungal and liposomal amphotericin B lock therapy in children with intestinal insufficiency with fungal catheter-related bloodstream infections whose central venous catheters had not been removed. Our results provide supportive evidence for the conduct of larger clinical trials to confirm the efficacy and safety of this approach.
[ctt tweet=”ReTweet if useful… Anti fungal central venous catheter lock therapy http://ctt.ec/sc0Wg+ @ivteam #ivteam” coverup=”sc0Wg”]
Reference:
McGhee, W., Michaels, M.G., Martin, J.M., Mazariegos, G.V. and Green, M. (2016) Antifungal Lock Therapy With Liposomal Amphotericin B: A Prospective Trial. Journal of the Pediatric Infectious Diseases Society. 5(1), p.80-4.
doi: 10.1093/jpids/piu083.
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]